Publication | Closed Access
2.23 Covalent Inhibition of Btk with Clinical Development Compound AVL-292 Disrupts Signaling That Maintains the Microenvironment Necessary for Chronic Lymphocytic Leukemia Growth
12
Citations
0
References
2011
Year
Hematological MalignancyLymphoid NeoplasiaImmunologyCovalent InhibitionMicroenvironment NecessaryAdult T-cell Leukemia-lymphomaMedicineCell BiologyTumor Microenvironment
No additional data available for this publication yet. Check back later!